Accredited Industry-Supported Symposium Breakfast: Beyond Clearance: Understanding the Value of PMA in Advanced Wound Therapies
90 min
Thursday, April 09, 2026
7:30 AM - 9:00 AM
HMP Education has designated an unrestricted grant from Organogenesis Inc.
Learning Objectives:
1. Describe the FDA Premarket Approval (PMA) process for skin substitutes, including key regulatory requirements and what PMA approval signifies regarding safety and efficacy.
2. Differentiate PMA-approved skin substitutes from other regulatory pathways, and discuss the clinical and practical implications of PMA status in wound care practice.
3. Evaluate the role of clinically proven PMA-approved products in improving patient outcomes, including how evidence-based product selection influences treatment decisions and quality of care.
Learning Objectives:
1. Describe the FDA Premarket Approval (PMA) process for skin substitutes, including key regulatory requirements and what PMA approval signifies regarding safety and efficacy.
2. Differentiate PMA-approved skin substitutes from other regulatory pathways, and discuss the clinical and practical implications of PMA status in wound care practice.
3. Evaluate the role of clinically proven PMA-approved products in improving patient outcomes, including how evidence-based product selection influences treatment decisions and quality of care.
-
ISS Speaker
-
Daniel Kapp MD -
-
Paula Pons MD, CWSP
-
-
Room
- 206